Physician
Cardiology
Dr. Peter E. Pool, MD
|
|
Give Review
Peter Pool is an expert in the field of Cardiology. He studied medicine at NYU School of Medicine. He has 1 awards "Fellow (FACC)". Peter Pool is a published MD as well. He has 68 publications published. The latest was: Neurohormonal activation in the treatment of congestive heart failure: basis for new treatments?
Publications
- Sinus arrest during REM sleep in young adults.
- The X-Ray CCDs Developed for the Joint European X-Ray Telescope.
- Double-blind crossover comparison of amlodipine at three dose levels and placebo in chronic stable angina.
- Dose-response range of encainide for benign and potentially lethal ventricular arrhythmias.
- Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias.
- Metabolic effects of antihypertensive therapy with a calcium antagonist.
- Efficacy of a new calcium antagonist PN 200-110 (isradipine) in angina pectoris.
- Sustained-release diltiazem: duration of antihypertensive effect.
- Effects of encainide on the function of implanted pacemakers.
- Treatment of ectopic atrial arrhythmias and premature atrial complexes in adults with encainide.
- Efficacy of encainide in supraventricular arrhythmias.
- Antihypertensive monotherapy with tablet (prompt-release) diltiazem: multicenter controlled trials.
- Metabolic consequences of treating hypertension.
- Influence of hyperthyroidism on glycerol-extracted cardiac muscle from rabbits.
- Augmented right ventricular function in systemic hypertension-induced hypertrophy.
- EXPERIMENTAL PULMONARY ARTERIAL HYPERTENSION IN THE NEWBORN CALF.
- ABSENT LEFT PULMONARY ARTERY AND RIGHT-SIDED PATENT DUCTUS ARTERIOSUS.
- Effect of ligation of left pulmonary artery at birth on maturation of pulmonary vascular bed.
- Congenital unilateral absence of a pulmonary artery. The importance of flow in pulmonary hypertension.
- Effects of intravenous dofetilide in patients with frequent premature ventricular contractions: a clinical trial.
- Does Chinese ethnicity affect the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors?
- Anomalies in the dosing of diltiazem.
- Neurohormonal activation in the treatment of congestive heart failure: basis for new treatments?
- The clinical significance of neurohormonal activation.
- Effect of morning versus evening dosing of diltiazem on myocardial ischemia detected by ambulatory electrocardiographic monitoring in chronic stable angina pectoris. D...
- Arbutamine vs. exercise stress testing in patients with coronary artery disease: evaluation by echocardiography and electrocardiography.
- Amlodipine once a day in stable angina: double-blind crossover comparison with placebo.
- The case for metabolic hypertension: is it time to restructure the hypertension paradigm?
- A randomized, controlled trial comparing diltiazem, hydrochlorothiazide, and their combination in the therapy of essential hypertension.
- Conversion from immediate-release to extended-release diltiazem in angina pectoris.
- Effects of sotalol on the function of implanted pacemakers.
- Stress testing with closed-loop arbutamine as an alternative to exercise. The International Arbutamine Study Group.
- Efficacy of diltiazem in angina on effort: a multicenter trial.
- The treatment of exercise-inducible chronic stable angina with diltiazem. Effect on treadmill exercise.
- Long-term efficacy of diltiazem in chronic stable angina associated with atherosclerosis: effect on treadmill exercise.
- Trimazosin for the treatment of hypertensive patients failing to respond to thiazides.
- Clinical hemodynamic profile of trimazosin in hypertension.
- Influence of the thyroid state on the intrinsic contractile properties and energy stores of the myocardium.
- Myocardial high energy phosphate stores in cardiac hypertrophy and heart failure.
- The mechanochemistry of cardiac muscle. I. The isometric contraction.
- Reduction of cardiac tyrosine hydroxylase activity in experimental congestive heart failure. Its role in the depletion of cardiac norepinephrine stores.
- Effects of acutely induced ischemic heart failure on myocardial high energy phosphate stores.
- Myocardial high energy phosphate stores in acutely induced hypoxic heart failure.
- Biochemical studies of energy production in the failing human heart.
- Mechanism of norepinephrine depletion in experimental heart failure produced by aortic constriction in the guinea pig.
- Mechanochemistry of cardiac muscle. IV. Utilization of high-energy phosphates in experimental heart failure in cats.
- Increased myocardial oxygen consumption and contractile state associated with increased heart rate in dogs.
- High-energy phosphate concentrations in dog myocardium during stress.
- Mechanism of action of digitalis glycosides (II).
- Sympathetic innervation of the developing rabbit heart. Biochemical and histochemical comparisons of fetal, neonatal, and adult myocardium.
- Mechanochemistry of cardia muscle. 3. Effects of norepinephrine on the utilization of high-energy phosphates.
- A biopsy drill permitting rapid freezing.
- Mechanochemistry of cardiac muscle. II. The isotonic contraction.
- Integrity of energy stores in cat papillary muscle. Effect of changes in temperature and frequency of contraction on high energy phosphate stores.
- Mechanochemistry of cardiac muscle. V. Influence of thyroid state on energy utilization.
- Neurotransmitter control of sinoatrial pacemaker frequency in isolated rat atria and in intact rabbits.
- Lactate and pyruvate concentrations in exercised ischemic canine muscle: relationship of tissue substrate level to lactate dehydrogenase isozyme pattern.
- Congestive heart failure following chronic tachycardia.
- Congestive heart failure: biochemical and physiologic observations.
- Relation of cardiac myofibrillar ATPase activity to increased contractile state.
- Fundamental mechanisms in congestive heart failure.
- Association of depressed myofibrillar adenosine triphosphatase and reduced contractility in experimental heart failure.
- Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension.
- Long-term monotherapy of angina pectoris with diltiazem.
- Diltiazem as monotherapy for systemic hypertension: a multicenter, randomized, placebo-controlled trial.
- Metabolic changes with antihypertensive therapy of the salt-sensitive patient.
- Treatment of supraventricular arrhythmias with encainide.
Schools
New York University
Barnes Hospital
National Heart Institute Nih
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
Washington University - Barnes-Jewish Hospital -
NYU School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Frank P. Carrea, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chad M. Bidart, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sridevi Challapalli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jerry N. Zebrack, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Letitia L. Anderson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph P. Stevenson, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard H. Bryan, MD |
|
|
Dr. Donald A. Spring, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. Grinsell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ram M. Challapalli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jake H. Ichino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William F. Graettinger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Candace M. McNulty, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kosta M. Arger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chanwit Roongsritong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stanley I. Thompson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anurag Mehta, MD
This Doctor is OpenDoctor Recommended.
|